Stocktoria
NewGenIvf Group Ltd NIVF
Nasdaq · stock · Services-Misc Health & Allied Services, NEC · website · IPO 2022-02-15
NewGenIvf Group Ltd financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $23.7M | $5.4M | $5.1M | $5.9M |
| Gross profit | $955,846 | $1.8M | $1.7M | $1.5M |
| Operating income | -$10.7M | -$1.2M | $42,242 | $398,705 |
| Interest expense | — | $765,177 | — | — |
| Income tax | — | -$486,706 | — | $208,141 |
| Net income | $9.9M | -$524,643 | $130,193 | $458,667 |
| EPS (diluted) | $3.04 | $-4408.76 | $13019.30 | $4.72 |
| Operating cash flow | -$10.9M | -$8.3M | -$1.8M | $1.7M |
| Free cash flow | -$11.1M | -$8.3M | -$1.8M | $1.6M |
| Cash & equivalents | $758,621 | $457,740 | $54,104 | $27,556 |
| Inventory | $335,360 | $80,813 | $126,264 | $46,910 |
| Total assets | $32.7M | $3.6M | $4.5M | $2.9M |
| Total liabilities | $6.7M | $5.1M | $1.2M | $2.8M |
| Shareholders' equity | $26.6M | -$1.5M | $3.7M | $563,113 |
Growth · year-over-year · Revenue CAGR 58.6%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +336.3% | +5.8% | -13.6% | — |
| Net income growth | — | -503.0% | -71.6% | — |
| EPS growth | — | -133.9% | +275732.6% | — |
| Free cash flow growth | — | — | -213.6% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.